Recently, microtubule inhibitors have emerged as potential targeted therapies for DYNC1H1-related spectrum disorders.[19] However, their use in DYNC1H1-related epilepsy has not yet been explored. This evidence concerns the gene DYNC1H1 and epilepsy.